GlassScriptPhysician profile
Catherine Ann Weymann
NPI 1518923069
$5,061.35
in general payments reported to CMS, 2019-2025
52 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $764 · 2021: $609 · 2022: $844 · 2023: $435 · 2024: $1,570 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,142 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,142.31 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.01 | 2021-2024 | Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $496.71 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $376.58 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $329.33 | 2019-2025 | |
| Lilly USA, LLC | $260.15 | 2019-2024 | Amyvid, Emgality, Kisunla |
| Biogen, INC. | $249.76 | 2019-2025 | Vumerity |
| Ucb, INC. | $240.61 | 2019-2025 | Rystiggo, Briviact |
| Sunovion Pharmaceuticals INC. | $224.39 | 2020-2022 | |
| Pfizer INC. | $208.46 | 2023-2025 | |
| Mdd US Operations, LLC | $150.63 | 2019-2025 | Apokyn, Xadago |
| Genentech USA, INC. | $137.70 | 2019-2025 | Ocrevus Zunovo |
| Jazz Pharmaceuticals INC. | $133.00 | 2020-2025 | |
| Celgene Corporation | $126.98 | 2022-2025 | Zeposia |
| Alexion Pharmaceuticals, INC. | $119.61 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $101.21 | 2020-2024 | Zeposia |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Weymann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.